Join
Live feed
·
INSIDERFilingvia Quantisnow
Precision BioSciences Inc. logo

Director Frankel Stanley converted options into 9,826 shares, increasing direct ownership by 231% to 14,078 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.